Search Results 681-690 of 17532 for corticosteroid

  1. Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment - Mayo Clinic

    No prolonged systemic corticosteroid treatment, except for topical ... Short duration (< 2 weeks) of systemic corticosteroids is allowed (e.g., for ...

  2. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies (ERADIC8) - Mayo Clinic

    Chronic systemic corticosteroid therapy for physiologic replacement (≤10 mg/day of prednisone equivalents) and the use of non-systemic corticosteroids ...

  3. Pulmonary Medicine News - Medical Professionals - Mayo Clinic

    Novel strategies that consider patient-specific variables, including markers of inflammation, may result in an individualized approach to corticosteroid use ...

  4. Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma - Mayo Clinic

    ... corticosteroid (ICS). The low-dose ICS may be either as ICS monotherapy or as an ICS/long-acting beta agonist (LABA) combination. The ICS component of the ...

  5. Clioquinol and hydrocortisone (topical route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Cream. Back to top ...

  6. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

    -Corticosteroid therapy within 2 weeks prior to first dose of study treatment, with the following exceptions: -Short course systemic corticosteroids (total ...

  7. A Study of What is Different in People with Alopecia Areata that Makes T cells Attack Hair Follicles - Mayo Clinic

    Subjects should not be pregnant or be on systemic corticosteroids; Subjects of any age, race, or gender will be included as long as they are able to provide ...

  8. Phase IIa Study Evaluating AZD7798 in Crohn's Disease (AMALTHEA) - Mayo Clinic

    Corticosteroid dependency (defined as inability to taper below budesonide 6 mg/day or prednisolone 10 mg/day without recurrent active disease) for the ...

  9. centers-of-excellence

    Faculty William Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D. Location Rochester, Minnesota Contact Tobin.Oliver@mayo.edu Clinical Profile ...

  10. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

    ... corticosteroids or immunosuppressive drugs ... Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or ...